
A week after The BMJ published a highly publicized paper claiming stem cell therapy can reduce the risk of heart failure, sleuths have unearthed what they are calling “serious” inconsistencies in the data.
The paper claims the phase III clinical trial published October 29 included over 400 patients in Shiraz, Iran, and tested whether stem cell therapy lowers the risk of heart failure after a heart attack.
The results were celebrated in a press release by the journal and appeared in several news outlets, with New Scientist calling the study the “strongest evidence yet that stem cells can help the heart repair itself.”
Continue reading Sleuths flag ‘complete mismatch’ in data of BMJ stem cell study







